Target intelligence / Profile preview

Vitamin B12 transport and receptor system

Molecular classification
Transporter, Receptor, Soluble carrier protein
01

Overview

The Vitamin B12 transport and receptor system is a multi-component physiological pathway essential for the absorption and cellular delivery of cobalamin. The process begins with Gastric Intrinsic Factor (GIF) binding dietary B12 in the small intestine, forming a complex that is recognized by the Cubam receptor—a heterodimer of Cubilin (CUBN) and Amnionless (AMN)—in the terminal ileum [1][2]. Following endocytosis and release into the bloodstream, B12 is bound by Transcobalamin II (TCN2) and delivered to peripheral tissues via the CD320 receptor [4]. This system is the primary therapeutic target for treating B12 deficiency and pernicious anemia through the administration of various cobalamin forms [3]. Beyond supplementation, the high-affinity Cubam-mediated uptake mechanism is being investigated as a vehicle for the oral delivery of therapeutic peptides and other poorly absorbed drugs [2]. Dysfunctions in this system, whether due to autoimmune destruction of intrinsic factor or genetic mutations in the receptors, lead to severe hematological and neurological disorders [3]. This entry is marked as incorrect because it aggregates multiple distinct proteins (GIF, CUBN, AMN, TCN2, and CD320) into a single functional system rather than a single molecular target.

Other names
Cobalamin transport systemIntrinsic factor-cobalamin receptor systemCubam complexIF-Cbl receptorTranscobalamin receptor system
02

Mechanism of action

Exogenous cobalamin ligands bind to transport proteins (Intrinsic Factor or Transcobalamin) to facilitate receptor-mediated endocytosis via the Cubam complex or CD320 receptor, restoring physiological vitamin levels.

03

Biological functions

Vitamin transportReceptor-mediated endocytosisMetabolic processIntestinal absorption
04

Disease associations

Pernicious anemiaImerslund-Gräsbeck syndromeMegaloblastic anemiaVitamin B12 deficiencyNeurological degeneration
05

Safety considerations

Autoimmune interference (anti-intrinsic factor antibodies)Malabsorption due to ileal resection or diseaseMasking of B12 deficiency by high folate intakeCompetitive inhibition by non-functional cobalamin analogues
06

Interacting drugs

Cyanocobalamin

3 more in the full profile.

07

Biomarkers

Serum Vitamin B12 levelsHolotranscobalamin (HoloTC)Methylmalonic acid (MMA)HomocysteineIntrinsic factor antibodies

Beyond the preview

Go deeper on Vitamin B12 transport and receptor system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitamin B12 transport and receptor system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call